Association between frequent CpG island methylation and HER2 amplification in human breast cancers

被引：0
|
作者：
Terada, Kotoe
Okochi-Takada, Eriko
Akashi-Tanaka, Sadako
Miyamoto, Kazuaki
Taniyama, Kiyomi
Tsuda, Hitoshi
Asada, Kiyoshi
Kaminishi, Michio
Ushijima, Toshikazu
机构：
[1] Natl Canc Ctr, Res Inst, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Tokyo, Japan
[3] Kure Med Ctr, Natl Hosp Org, Kure, Japan
[4] Univ Tokyo, Sch Med, Tokyo 113, Japan
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-165
引用
收藏
页数：1
相关论文
共 50 条
  • [21] HER2 Positive Breast Cancers with Progression
    Solanki, Malvika
    Chitambar, Christopher
    Jorns, Julie
    LABORATORY INVESTIGATION, 2019, 99
  • [22] HER2 Positive Breast Cancers with Progression
    Solanki, Malvika
    Chitambar, Christopher
    Jorns, Julie
    MODERN PATHOLOGY, 2019, 32
  • [23] Frequent alterations of HER2 through mutation, amplification, or overexpression in pleomorphic lobular carcinoma of the breast
    Huang-Chun Lien
    Yu-Ling Chen
    Yu-Lin Juang
    Yung-Ming Jeng
    Breast Cancer Research and Treatment, 2015, 150 : 447 - 455
  • [24] Frequent alterations of HER2 through mutation, amplification, or overexpression in pleomorphic lobular carcinoma of the breast
    Lien, Huang-Chun
    Chen, Yu-Ling
    Juang, Yu-Lin
    Jeng, Yung-Ming
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (02) : 447 - 455
  • [25] Alterations in the TOP2A and HER2 Genes: Association With Adjuvant Anthracycline Sensitivity in Human Breast Cancers
    Slamon, Dennis J.
    Press, Michael F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (09): : 615 - 618
  • [26] Borderline HER2 Protein Positive Breast Cancers Have Similar Patient Outcome Regardless of HER2 Gene Amplification Status
    Barros, F.
    Aleskandarany, M.
    Rakha, E.
    Watts, S.
    Powe, D.
    Ellis, I
    Green, A.
    JOURNAL OF PATHOLOGY, 2010, 222 : S23 - S23
  • [27] Comparison of the seric dosage of HER2 extracellular domain with hyperexpression-amplification of HER2 studied on metastasis biopsies of breast cancers
    Thery, J. C.
    Picquenot, J. M.
    Cornic, M.
    Lamarche, C.
    Raillot, V
    Laberge-Le-Couteulx, S.
    Veyret, C.
    Basuvau, J. P.
    Blot, E.
    BULLETIN DU CANCER, 2008, 95 (06) : 607 - 608
  • [28] BORDERLINE HER2 PROTEIN POSITIVE BREAST CANCERS HAVE SIMILAR PATIENT OUTCOME REGARDLESS OF HER2 GENE AMPLIFICATION STATUS
    Barros, F. F. T.
    Aleskandarany, M.
    Rakha, E.
    Watts, S. L.
    Powe, D. G.
    Ellis, I. O.
    Green, A. R.
    EJC SUPPLEMENTS, 2010, 8 (06): : 6 - 7
  • [29] The Effect of HER2 Amplification in HER2+Breast Cancer
    Lee, M. K.
    Hurvitz, S. A.
    Tran, B. N.
    Fu, Y.
    Chung, D. U.
    Gornbein, J.
    Apple, S. K.
    Chang, H. R.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S45 - S45
  • [30] Efficacy of HER2 inhibitors in metastatic breast cancer by discordance in HER2 amplification status between primary and metastatic breast cancer
    Van Raemdonck, E.
    Berteloot, P.
    Laenen, A.
    Han, S.
    Van Nieuwenhuysen, E.
    Salihi, R.
    Concin, N.
    Vergote, I.
    Floris, G.
    Wildiers, H.
    Punie, K.
    Neven, P.
    CANCER RESEARCH, 2019, 79 (04)
12345